South Korea Electrocardiograph (ECG) Market

South Korea Electrocardiograph (ECG) Market Analysis

The South Korea Electrocardiograph Market size is estimated at USD 36.58 million in 2025, and is expected to reach USD 47.52 million by 2030, at a CAGR of 5.37% during the forecast period (2025-2030).

An electrocardiograph, also known as an ECG or EKG, is a medical device that records the heart's electrical activity over time. The significant factors contributing to the market growth of the ECG market in South Korea include the rising cardiovascular disease prevalence, technological advancements, and artificial intelligence (AI) integration coupled with increasing government initiatives and healthcare investments. In addition, the increasing adoption of telemedicine and home-based monitoring of heart health further contributes to the market growth of ECG in South Korea.

In South Korea, an aging population, sedentary lifestyles, and rising obesity rates are intensifying the burden of cardiovascular diseases. This surge in cardiovascular issues is, in turn, amplifying the demand for ECG devices, crucial for early diagnosis and monitoring. For instance, an article published in the Journal of Clinical Medicine in January 2023 mentioned that around 105,000 stroke incidents, both first-time and repeat occurrences, affect Korean individuals every year. Thus, this substantial cardiovascular challenge and the heightened demand for diagnostic tools, particularly ECG devices, are propelling market growth.

Moreover, the market dynamics are being shaped by the growing investments by the government to boost the medical technology sector, which enhance diagnostic precision and efficiency. For instance, in June 2024, South Korean technology regulators planned to invest USD 1.59 billion (KRW 2.2 trillion) in healthcare technology research and development (R&D) in 2024. This investment will be coupled with a greater focus on expanding international research collaborations to secure global leadership and build cooperative research networks with leading countries in the biotechnology sector. Such government investments is anticipated to contribute to the studied market's expansion.

Therefore, the electrocardiograph market in South Korea is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases and the adoption of innovative technologies. However, the high cost of advanced ECG devices can restrict their adoption in smaller clinics and rural hospitals, which may consequently slow down market expansion within the country.

South Korea Electrocardiograph (ECG) Market Trends

Holter ECG Systems Segment is Expected to Have Significant Growth in the Market Over the Forecast Period

South Korea's Holter ECG systems segment is experiencing a significant uptick driven by its pivotal role in addressing cardiovascular challenges. Technological advancements in Holter monitors and the burgeoning fields of telemedicine and remote patient monitoring underscore this surge. Such developments underscore the segment's vital contribution to the escalating demand for precise and effective diagnostic tools in the broader ECG landscape.

Holter ECG systems are portable devices that continuously monitor the heart's electrical activity. While standard models record for 24 to 48 hours, advanced versions can extend this monitoring period to 14 days. These systems are instrumental in identifying intermittent heart abnormalities that shorter ECG tests might avoid. For instance, a study published in Scientific Reports in March 2023, highlighted that participants used the WearECG12 (Healthrian), a Holter ECG device approved by the Korean Ministry of Food and Drug Administration, to perform their own 12-lead ECG examinations. The results demonstrated that individuals without medical training could successfully conduct these examinations and receive results via a mobile device within ten minutes. This highlights the potential for significant growth in the Holter ECG systems segment within the electrocardiograph market in South Korea, driven by increasing accessibility and ease of use for non-medical professionals.

Additionally, the increasing geriatric population further escalates the demand for Holter ECG systems for remote monitoring. For instance, according to the data from Statistics Korea published in September 2024, senior citizens comprised a significant portion of South Korea's population in 2024, with 9.94 million individuals representing 19.2% of the country's 51.75 million residents. The Holter ECG systems segment in South Korea's electrocardiograph market is expected to witness significant growth, driven by the increasing aging population who are more prone to cardiovascular diseases, fueling the need for portable diagnostic technologies.

ECG Management Software is Expected to Have Fastest Growth in the Market Over the Forecast Period

Healthcare providers use ECG management software to efficiently collect, store, analyze, and manage electrocardiogram (ECG) data. This software works with various ECG devices, including resting ECGs, Holter monitors, and stress ECGs. Additionally, it integrates ECG results with electronic medical records (EMRs/EHRs) and supports remote or AI-driven analysis. The segment growth is driven by various factors, such as the Korean government's investments in digital health and artificial intelligence (AI), expansion of telemedicine and remote cardiac monitoring, and AI and machine learning integration in ECG analysis.

The high burden of obesity is significantly associated with heart disorders such as hypertension, coronary artery disease, atrial fibrillation, and heart failure. Excess weight significantly elevates the risk of heart disorders due to physiological and hormonal shifts triggered by increased body fat. Increased body fat leads to a rise in blood volume, requiring the heart to pump harder to circulate blood. This increased workload elevates blood pressure and puts undue stress on the arteries. This will lead to a higher demand for ECG screenings to diagnose cardiac abnormalities, thus boosting the need for ECG management software to enhance accuracy in diagnosis.

For instance, the data published by the Global Obesity Observatory in 2024 reported that around 49.1% of men and 29.2% of women in South Korea had obesity in 2024. Thus, the significant burden of obesity further escalates the demand for ECG management software for the early detection of heart diseases, thereby propelling the market's growth.

The growing initiatives and collaborations of government further drives the need for ECG management software for ECG check-ups, driving the segment growth. For instance, in September 2024, in partnership with the Korea Medical Device Association (KMDA), Messe Düsseldorf GmbH showcased the "Korean Health Check-up," a vital component of the future of healthcare. This exhibition offered a hands-on experience with diagnostic software used in the detection of breast cancer, esophageal cancer, and ECG abnormalities. These cutting-edge software solutions deliver in-depth analysis for diverse medical specialties, such as endoscopy, ECG, and ultrasound imaging. Thus, such initiatives to enhance the healthcare efficiency is likely to support the ECG management software segment.

South Korea Electrocardiograph (ECG) Industry Overview

In South Korea, the competitive landscape of the electrocardiograph (ECG) market is characterized by the combination of global medical device companies, local firms, and emerging digital health startups competing for dominance in the ECG market, which remains moderately fragmented. This landscape has intensified price competition, especially in the segment for portable and affordable ECG machines, where both domestic and international players are in strong competition. Some of the key market players include GE HealthCare, Nihon Kohden Corporation, Fukuda Denshi Co., Ltd, Bionet and Koninklijke Philips N.V., among others.

South Korea Electrocardiograph (ECG) Market Leaders

South Korea Electrocardiograph (ECG) Market News

• November 2024: VUNO, a South Korean AI medical device company, received approval from the Ministry of Food and Drug Safety (MFDS) for its AI-powered software, VUNO Med-DeepECG Hyperkalemia. This software leverages deep learning algorithms to analyze electrocardiogram (ECG) data, enabling non-invasive and precise detection of hyperkalemia. VUNO intended to combine DeepECG Hyperkalemia with its HATIV P30 ECG monitoring device, facilitating widespread routine monitoring within healthcare settings. This development broadened the scope of DeepECG beyond cardiovascular ailments to encompass kidney-related conditions.
• June 2024: Philips Korea and Chung-Ang University Gwangmyeong Hospital collaborated in a memorandum of understanding (MOU) to create a smart electrocardiogram (ECG) big data system. As part of the agreement, the hospital implemented Philips' IntelliSpace ECG Management System to collect extensive ECG data and develop artificial intelligence (AI) algorithms to improve the accuracy and efficiency of cardiovascular and cerebrovascular diagnoses.